New drug trial aims to tame lupus and arthritis
NCT ID NCT07276958
First seen Jan 09, 2026 · Last updated Jun 16, 2026 · Updated 26 times
Summary
This early-stage study tests a new medicine called LY4298445 to see if it is safe and tolerable. It involves healthy volunteers and people with lupus or rheumatoid arthritis. Participants receive either the drug or a placebo and are followed for up to a year. The goal is to understand how the body processes the drug and its effects on immune cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nucleus Network
RECRUITINGBrisbane, 4006, Australia
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.